Literature DB >> 11422912

Hereditary human complement C3 deficiency owing to reduced levels of C3 mRNA.

A G Ulbrich1, M P Florido, V Nudelman, E S Reis, G V Baracho, L Isaac.   

Abstract

An 8-year-old son (L.A.S.) of consanguineous parents, presented recurrent bacterial infections, vasculitis and extremely low levels of serum C3 (0.15 microg/ml). The classical and alternative pathway haemolytic activities and the generation of opsonins and chemotactic factors derived from the activation of the complement system were markedly affected in the proband's serum. An in vitro addition of purified C3 restored the classical pathway-dependent haemolytic activity of his serum. Autoradiographs of the proband's lipopolysaccharide (LPS)-stimulated and 35S-labelled fibroblast supernatants after that the SDS-PAGE revealed no C3 alpha or beta chains. The amount of C3 mRNA synthesized by the proband's fibroblasts, as evaluated by reverse transcription-polymerase chain reaction (RT-PCR) assays, was greatly reduced.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11422912     DOI: 10.1046/j.1365-3083.2001.00934.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  6 in total

1.  Homozygous hereditary C3 deficiency due to a premature stop codon.

Authors:  Edimara Da Silva Reis; Gisele Vanessa Baracho; Adriana Sousa Lima; Chuck S Farah; Lourdes Isaac
Journal:  J Clin Immunol       Date:  2002-11       Impact factor: 8.317

Review 2.  Complement component C3 - The "Swiss Army Knife" of innate immunity and host defense.

Authors:  Daniel Ricklin; Edimara S Reis; Dimitrios C Mastellos; Piet Gros; John D Lambris
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

3.  Simple method to distinguish between primary and secondary C3 deficiencies.

Authors:  Marlene Pereira de Carvalho Florido; Patrícia Ferreira de Paula; Lourdes Isaac
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

4.  Nonsense-codon-mediated decay in human hereditary complement C3 deficiency.

Authors:  Edimara S Reis; Victor Nudelman; Lourdes Isaac
Journal:  Immunogenetics       Date:  2003-11-25       Impact factor: 2.846

5.  Molecular characterization of homozygous hereditary factor I deficiency.

Authors:  G V Baracho; V Nudelman; L Isaac
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

6.  Screening for C3 deficiency in newborns using microarrays.

Authors:  Magdalena Janzi; Ronald Sjöberg; Jinghong Wan; Björn Fischler; Ulrika von Döbeln; Lourdes Isaac; Peter Nilsson; Lennart Hammarström
Journal:  PLoS One       Date:  2009-04-24       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.